FDA
Date Range
Score Range
FDA portrayed as in institutional crisis due to leadership instability
[framing_by_emphasis], [editorializing]
“Hoeg’s departure is the latest in an ongoing shake-up at the powerful regulatory agency. FDA Commissioner Marty Makary resigned earlier in the week, and Dr. Vinay Prasad, the agency’s vaccine and biotech chief, stepped down last month following intense criticism from drugmakers, patients and investors.”
Framed as internally conflicted and vulnerable to politicization
The article highlights Høeg's challenges to FDA decisions and controversial background without including expert validation of agency science, creating a subtle framing of institutional instability and questionable integrity.
“Høeg garnered controversy during her brief tenure at FDA for challenging the agency’s own decisions.”
FDA portrayed as failing to ensure public safety
Loaded language and emotional examples used to emphasize institutional breakdown and real-world harm
“Trust in the agency — among the public and among the scientists who make the work happen — has plummeted.”
FDA portrayed as dysfunctional and unstable due to leadership turnover and political interference
The article emphasizes repeated leadership changes, forced staff departures, and internal conflict, framing the agency as failing under political pressure.
“His exit adds to a multitude of public health vacancies under the leadership of Health and Human Services secretary Robert F. Kennedy Jr., whose views on vaccines have rankled many in the health community.”
FDA portrayed as in a state of crisis and instability
[framing_by_emphasis] and [omission] — Emphasis on repeated leadership changes, acting appointments, and internal conflict frames the agency as unstable. Omission of policy rationale deepens perception of chaos.
“His exit adds to a multitude of public health vacancies under the leadership of Health and Human Services secretary Robert F. Kennedy Jr., whose views on vaccines have rankled many in the health community.”
FDA leadership and stability portrayed as failing due to mass departures and controversy
[cherry_picking] and [contextual completeness] omissions emphasizing negative developments without balancing defense of leadership
“Over the past week, reports of Makary's potential exit have intensified over concerns tied to controversial decisions on drug approvals, vaccines and the FDA's handling of the abortion pill mifepristone. Under Mak游戏副本y and Health Secretary Robert F. Kennedy Jr., thousands of employees have left the agency through firings and voluntary departures, including at the large divisions overseeing reviews of new drugs.”
Frames the FDA as institutionally vulnerable and under political siege
[omission] and contextual framing: While the article omits direct mention of staff departures, it implies institutional instability by noting Makary 'beat back previous efforts to oust him' and that 'thousands of staff members left,' suggesting the agency is under sustained threat.
“He was an ally of Health Secretary Robert F. Kennedy Jr.’s Make American Healthy Again supporters, voicing the skepticism of the pharmaceutical industry and authorizing natural food dyes.”
FDA's regulatory consistency questioned due to perceived reversal under pressure
[cherry_picking] — juxtaposes past caution with current approval without explaining scientific evolution, implying inconsistency
“U.S. regulators have avoided granting licenses to vapes, and the FDA has said it would continue to require a heavy burden of evidence of benefits to smokers for vape flavors that also have strong appeal to youth, such as fruit or candy flavors”
Regulatory decision portrayed as influenced by politics rather than science
[framing_by_emphasis] in headline and narrative highlights political pressure, potentially undermining perception of FDA's scientific independence
“FDA authorizes first fruit-flavored e-cigarettes in US amid political pressure”
FDA leadership is portrayed as morally detached and unaccountable
Loaded language such as 'gilded office' and 'lost touch' frames FDA officials as elitist and indifferent, implying a failure of integrity and empathy rather than procedural rigor.
“I asked Food & Drug Administration (FDA) Commissioner Dr. Martin Makary to leave his gilded office and come visit my home, because I fear that he’s lost touch with terminally ill children like Ryu.”